Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Christine D. Berg"'
Autor:
Katie E. Lichter, Justin Anderson, Austin J. Sim, Claire C. Baniel, Cassandra L. Thiel, Robert Chuter, Amy Collins, Erin Carollo, Christine D Berg, C. Norman Coleman, May Abdel-Wahab, Surbhi Grover, Lisa Singer, Osama Mohamad
Publikováno v:
Int J Radiat Oncol Biol Phys
Autor:
Nicole Urban, Claire S. Zhu, Zhen Zhang, David C. Ward, Sudhir Srivastava, Patrick M. Sluss, Steven J. Skates, Nathalie Scholler, Mark D. Thornquist, Paul F. Pinsky, Christos Patriotis, Gil Mor, Martin W. McIntosh, Karen H. Lu, Anna E. Lokshin, Patricia Hartge, Andrew K. Godwin, Eleftherios P. Diamandis, Christine D. Berg, Robert C. Bast, Daniel W. Cramer
Establishing a cancer screening biomarker's intended performance requires “phase III” specimens obtained in asymptomatic individuals before clinical diagnosis rather than “phase II” specimens obtained from symptomatic individuals at diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf1e70b162e8cd9fbba21a5004249ba5
https://doi.org/10.1158/1940-6207.c.6544857
https://doi.org/10.1158/1940-6207.c.6544857
Autor:
Nicole Urban, Claire S. Zhu, Zhen Zhang, David C. Ward, Sudhir Srivastava, Patrick M. Sluss, Steven J. Skates, Nathalie Scholler, Mark D. Thornquist, Paul F. Pinsky, Christos Patriotis, Gil Mor, Martin W. McIntosh, Karen H. Lu, Anna E. Lokshin, Patricia Hartge, Andrew K. Godwin, Eleftherios P. Diamandis, Christine D. Berg, Robert C. Bast, Daniel W. Cramer
Perspectives on This Article from Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0327c80f36bfd0572b80a18ce723774d
https://doi.org/10.1158/1940-6207.22525686.v1
https://doi.org/10.1158/1940-6207.22525686.v1
Autor:
Amanda Black, Hormuzd A. Katki, Robert L. Grubb, Christine D. Berg, Lauren C. Houghton, Rebecca Landy
Longer-than-annual screening intervals have been suggested to improve the balance of benefits and harms in prostate cancer screening. Many researchers, societies, and guideline committees have suggested that screening intervals could depend on the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6234bc48fbba50b1d6d31ec7b16b0fc
https://doi.org/10.1158/1940-6207.c.6547666.v1
https://doi.org/10.1158/1940-6207.c.6547666.v1
Autor:
Christine D. Berg, Saundra S. Buys, Sudhir Srivastava, Christos Patriotis, Adele M. Marrangoni, Karen H. Lu, Nathalie Scholler, Patrick M. Sluss, Eric T. Fung, Aleksey Lomakin, James T. Symanowski, David C. Ward, Zhen Zhang, Allison Vitonis, Steven J. Skates, Martin W. McIntosh, Anna E. Lokshin, Lee E. Moore, Robert C. Bast, Gil Mor, Nicole Urban, Ruth M. Pfeiffer, Patricia Hartge, David F. Ransohoff, Daniel W. Cramer, Paul F. Pinsky, Claire S. Zhu
A panel of biomarkers may improve predictive performance over individual markers. Although many biomarker panels have been described for ovarian cancer, few studies used prediagnostic samples to assess the potential of the panels for early detection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5efdfd15abacb677fe17610c36b679fb
https://doi.org/10.1158/1940-6207.c.6544599
https://doi.org/10.1158/1940-6207.c.6544599
Autor:
Christine D. Berg, Saundra S. Buys, Sudhir Srivastava, Christos Patriotis, Adele M. Marrangoni, Karen H. Lu, Nathalie Scholler, Patrick M. Sluss, Eric T. Fung, Aleksey Lomakin, James T. Symanowski, David C. Ward, Zhen Zhang, Allison Vitonis, Steven J. Skates, Martin W. McIntosh, Anna E. Lokshin, Lee E. Moore, Robert C. Bast, Gil Mor, Nicole Urban, Ruth M. Pfeiffer, Patricia Hartge, David F. Ransohoff, Daniel W. Cramer, Paul F. Pinsky, Claire S. Zhu
Perspectives on This Article from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef42eb78d3a5eef0b36c34e0a3de94b
https://doi.org/10.1158/1940-6207.22525149
https://doi.org/10.1158/1940-6207.22525149
Autor:
Christine D. Berg, Saundra S. Buys, Sudhir Srivastava, Christos Patriotis, Adele M. Marrangoni, Karen H. Lu, Nathalie Scholler, Patrick M. Sluss, Eric T. Fung, Aleksey Lomakin, James T. Symanowski, David C. Ward, Zhen Zhang, Allison Vitonis, Steven J. Skates, Martin W. McIntosh, Anna E. Lokshin, Lee E. Moore, Robert C. Bast, Gil Mor, Nicole Urban, Ruth M. Pfeiffer, Patricia Hartge, David F. Ransohoff, Daniel W. Cramer, Paul F. Pinsky, Claire S. Zhu
Supplementary Materials from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331c0cc2086b8e679b5458911c6cfcac
https://doi.org/10.1158/1940-6207.22525146.v1
https://doi.org/10.1158/1940-6207.22525146.v1
Autor:
Peter Kraft, Regina G. Ziegler, Elio Riboli, Rudolf Kaaks, Shumin M. Zhang, Meredith Yeager, Walter C. Willett, Stephanie J. Weinstein, Jarmo Virtamo, Rosario Tumino, Dimitrios Trichopoulos, Anne Tjønneland, Michael J. Thun, Gilles Thomas, Daniel O. Stram, Pär Stattin, Meir J. Stampfer, Maria-José Sánchez, Carlotta Sacerdote, Laudina Rodriguez, Kim Overvad, N. Charlotte Onland-Moret, Jing Ma, Eiliv Lund, Loic LeMarchand, I-Min Lee, Pagona Lagiou, Laurence N. Kolonel, Kay-Tee Khaw, Timothy J. Key, Mattias Johansson, Robert N. Hoover, David J. Hunter, Brian E. Henderson, Richard B. Hayes, Susan E. Hankinson, Christopher A. Haiman, Edward L. Giovannucci, J. Michael Gaziano, Vanessa Dumeaux, Françoise Clavel-Chapelon, Stephen J. Chanock, Nathalie Chabbert-Buffet, Julie E. Buring, H. Bas Bueno-de-Mesquita, Heiner Boeing, Sonja I. Berndt, Christine D. Berg, Demetrius Albanes, Naomi E. Allen, Federico Canzian, Fredrick R. Schumacher, Fangyi Gu
Background: Circulating levels of insulin-like growth factor I (IGF-I) and its main binding protein, IGF binding protein 3 (IGFBP-3), have been associated with risk of several types of cancer. Heritable factors explain up to 60% of the variation in I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6863fdc5f1d792fdeb5d088623897fda
https://doi.org/10.1158/1055-9965.c.6516024
https://doi.org/10.1158/1055-9965.c.6516024
Autor:
Peter Kraft, Regina G. Ziegler, Elio Riboli, Rudolf Kaaks, Shumin M. Zhang, Meredith Yeager, Walter C. Willett, Stephanie J. Weinstein, Jarmo Virtamo, Rosario Tumino, Dimitrios Trichopoulos, Anne Tjønneland, Michael J. Thun, Gilles Thomas, Daniel O. Stram, Pär Stattin, Meir J. Stampfer, Maria-José Sánchez, Carlotta Sacerdote, Laudina Rodriguez, Kim Overvad, N. Charlotte Onland-Moret, Jing Ma, Eiliv Lund, Loic LeMarchand, I-Min Lee, Pagona Lagiou, Laurence N. Kolonel, Kay-Tee Khaw, Timothy J. Key, Mattias Johansson, Robert N. Hoover, David J. Hunter, Brian E. Henderson, Richard B. Hayes, Susan E. Hankinson, Christopher A. Haiman, Edward L. Giovannucci, J. Michael Gaziano, Vanessa Dumeaux, Françoise Clavel-Chapelon, Stephen J. Chanock, Nathalie Chabbert-Buffet, Julie E. Buring, H. Bas Bueno-de-Mesquita, Heiner Boeing, Sonja I. Berndt, Christine D. Berg, Demetrius Albanes, Naomi E. Allen, Federico Canzian, Fredrick R. Schumacher, Fangyi Gu
Supplementary Table 1 from Eighteen Insulin-like Growth Factor Pathway Genes, Circulating Levels of IGF-I and Its Binding Protein, and Risk of Prostate and Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ea6bf9b59e384dfe24513480defbf6
https://doi.org/10.1158/1055-9965.22437762.v1
https://doi.org/10.1158/1055-9965.22437762.v1
Autor:
David R Baldwin, Hormuzd A. Katki, Li C. Cheung, Christine D. Berg, Anil K. Chaturvedi, Hilary A. Robbins
Publikováno v:
J Thorac Oncol
Objectives We propose a risk-tailored approach for management of lung cancer screening results. This approach incorporates individual risk factors and low-dose computed tomography (LDCT) image features into calculations of immediate and next-screen (